Latest Lupus Nephritis News
The development of this scale, once further validated, will give clinicians the ability to verify lupus nephritis activity without the need for an invasive kidney biopsy.
Among the findings, researchers found no association between mixed or pure histopathologic features of LN at presentation and rates of complete or partial remission.
Researchers find an increased risk of death among patients.
Athcar gel may be a treatment option for patients with treatment-resistant nephrotic syndrome.
Antimalarial protects against metabolic syndrome, countering steroid effects.
No change in interferon signature in vitamin D-deficient patients, those with vitamin D repletion.
Increased risk of systemic lupus erythematosus, lupus nephritis with copy number loss, not gain.
Urinary red blood cells undermine a composite prediction of renal outcome.
New study also provides evidence that an early proteinuria decrease is a strong predictor of good long-term outcome.
Minority race/ethnicity and lack of private insurance associated with inadequate care in U.S.
The risk of end-stage renal disease in patients with systemic lupus erythematosus may even be declining, but outcomes differ by race.
The condition appears to be associated with high hospitalization and death rates, researchers reported.
Half of those lupus nephritis patients taking three medications achieved full remission.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)